Knowledge Distillery

Serum neurofilament light chain (sNfL) is an established biomarker of neuro-axonal damage in multiple neurological disorders.

SARS-CoV-2 uses ACE2, an inhibitor of the Renin-Angiotensin-Aldosterone System (RAAS), for cellular entry. Studies indicate that RAAS imbalance…

COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses.

Since the COVID-19 pandemic, caused by SARS-CoV-2, a growing body of evidence indicates that, besides common COVID-19 symptoms, patients may develop…

In this longitudinal study, recently published in the European Journal of Neurology, the authors sought to describe the neurological manifestations of…

Clinical outcome following infection with SARS-CoV-2 ranges from silent infection to lethal COVID-19.

Inter-individual clinical variability in the course of SARS-CoV-2 infection is immense.

The objective of this article recently published in Neurology Neuroimmunology & Neuroinflammation was to investigate the pathophysiological mechanism…

There is increasing evidence that patients with COVID-19 can present with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea…

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, binds to its receptor angiotensin-converting…

The literature on neurological manifestations in COVID-19 patients has been rapidly increasing with the pandemic. However, data on CNS inflammatory…

Though SARS-CoV-2 primarily targets the respiratory system, patients and survivors can suffer neurological symptoms. Yet, an unbiased understanding of…